AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

AstraZeneca shared the topline result from the placebo-controlled ... before AZ and its partner Merck were able to cross the ...

AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior ...

AstraZeneca raises its fiscal 2024 guidance for the second consecutive quarter. This upgrade comes despite ongoing legal ...

AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper ...

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of ...

AstraZeneca said it doesn’t comment on ... The shares closed down 8.4%, the steepest one-day decline since March 2020. That took the stock to its lowest since March. The probe has created ...

AstraZeneca has upgraded its revenue and earnings guidance for this year. Total revenues and core earnings per share rose 21% ...

AstraZeneca’s top executive in China, Leon Wang, has been detained by Chinese authorities over the past week, the drugmaker told the Financial Times. The FTSE 100 company confirmed that the head of ...

Pascal Soriot, CEO of AstraZeneca, said the growth in total revenue and core earnings per share reflected the "increasing ...